Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological Standardization of Dactylis Glomerata Allergen Extract
NCT01407835Phase 2Completed
- Sponsor
- LETI Pharma
- Start
- Oct 2011
- Primary completion
- Mar 2012
- Modality
- Allergy Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of dactylis glomerata allergen extract in allergic rhinitis due to grass pollen, sponsored by LETI Pharma. Started Oct 2011; status: completed.
02
Drugs
dactylis glomerata allergen extract
03
Conditions
allergic rhinitis due to grass pollen
Beyond the preview
Go deeper on NCT01407835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407835.